Randomised phase II study of Intra-arterial infusion therapy with cisplatin suspension in lipiodol and 5-fluorouracil(New FP therapy)versus sorafenib in advanced hepatocellular carcinoma.
Latest Information Update: 24 Nov 2018
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin; Ethiodized oil; Fluorouracil
- Indications Liver cancer
- Focus Therapeutic Use
- 16 Nov 2018 Planned End Date changed from 1 May 2020 to 1 May 2018.
- 16 Nov 2018 Status changed from recruiting to discontinued.
- 04 Nov 2016 New trial record